ProPhase Labs, Inc. (PRPH) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
ProPhase Labs, Inc. (PRPH) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $420,486, listed on OTC, employing roughly 19 people, carrying a beta of 0.13 to the broader market. ProPhase Labs, Inc. Led by Ted William Karkus, public since 1994-04-04.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for PRPH as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.